Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acquired heart disease with argentaffin carcinoma.

Literature DB >> 13374161

Acquired heart disease with argentaffin carcinoma.

A J GOBLE, D R HAY, R HUDSON, M SANDLER.

Abstract

Entities: Disease

Keywords: ARGENTAFFINOMA/case reports; HEART DISEASES/etiology and pathogenesis; PULMONARY STENOSIS/etiology and pathogenesis; TRICUSPID VALVE/stenosis

Mesh：

Year: 1956 PMID： 13374161 PMCID： PMC503986 DOI： 10.1136/hrt.18.4.544

Source DB: PubMed Journal: Br Heart J ISSN： 0007-0769

× No keyword cloud information.

10 in total

1. The syndrome of carcinoid and acquired valve lesions of the right side of the heart.

Authors: W B BEAN; D OLCH; H B WEINBERG
Journal: Circulation Date: 1955-07 Impact factor: 29.690

2. 5-Hydroxytryptamine metabolism in acquired heart-disease associated with argentaffin carcinoma.

Authors: A J GOBLE; D R HAY; M SANDLER
Journal: Lancet Date: 1955-11-12 Impact factor: 79.321

3. Malignant argentaffinoma with cyanosis and pulmonary stenosis.

Authors: J S JENKINS; P J BUTCHER
Journal: Lancet Date: 1955-02-12 Impact factor: 79.321

4. Argentaffinoma as endocrine tumour.

Authors: I H PAGE; A C CORCORAN; S UDENFRIEND; A SZOEDSMA; H WEISSBACH
Journal: Lancet Date: 1955-01-22 Impact factor: 79.321

5. Carcinoid tumour of small intestine, with hepatic metastases, pulmonary stenosis, and atypical cyanosis.

Authors: A W BRANWOOD; A D BAIN
Journal: Lancet Date: 1954-12-18 Impact factor: 79.321

6. Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumours.

Authors: B PERNOW; J WALDENSTROM
Journal: Lancet Date: 1954-11-06 Impact factor: 79.321

7. Some neurophysiological aspects of serotonin.

Authors: D W WOOLLEY; E SHAW
Journal: Br Med J Date: 1954-07-17

8. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors: A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal: Am Heart J Date: 1954-06 Impact factor: 4.749

9. Nature of the lung enzyme which inactivates serum vasoconstrictor.

Authors: T R BRADLEY; R F BUTTERWORTH; G REID; E M TRAUTNER
Journal: Nature Date: 1950-11-25 Impact factor: 49.962

10. Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiography.

Authors: G BIORCK; O AXEN; A THORSON
Journal: Am Heart J Date: 1952-07 Impact factor: 4.749

10 in total

5 in total

Acquired heart disease with argentaffin carcinoma.

1. The syndrome of carcinoid and acquired valve lesions of the right side of the heart.

2. 5-Hydroxytryptamine metabolism in acquired heart-disease associated with argentaffin carcinoma.

3. Malignant argentaffinoma with cyanosis and pulmonary stenosis.

4. Argentaffinoma as endocrine tumour.

5. Carcinoid tumour of small intestine, with hepatic metastases, pulmonary stenosis, and atypical cyanosis.

6. Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumours.

7. Some neurophysiological aspects of serotonin.

9. Nature of the lung enzyme which inactivates serum vasoconstrictor.

10. Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiography.

1. Metastatic argentaffinoma secreting 5-hydroxytryptamine in a patient with a patent foramen ovale.

2. Development of valvular lesions in metastatic carcinoid disease.

3. Carcinoid heart disease.

4. Malignant carcinoid tumours.

5. Tricuspid valve replacement in carcinoid heart disease.